Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Phl p 5Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.9 - Pollen Allergy2014Czech RepublicIgE82644.70020140606, Panzner P
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE10362.80020141003, Beitia JM
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE10181.19020140306, Darsow U
1.11 - Esophagitis, Diagnosed2014SpainIgE6710.50020140625, Armentia A
5.2.5 - Source Exposed, Children (Symptoms, IgE)2014SpainIgE5558.18020140618, Cases B
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.9 - Pollen Allergy2014SpainIgE5012.00020140625, Armentia A
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3730.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE2832.00020140127, Konradsen JR
1.4 - Respiratory Symptoms, Diagnosed2014ItalyIgE2176.20020141114, Costa C
1.4 - Respiratory Symptoms, Diagnosed2013SpainIgE18719.30020131016, Feliu A
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14027.14020130111, Ott H
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7634.20020131020, van Rhijn BD
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4955.10020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4957.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4951.00020131014, Bokanovic D
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3551.43020130605, Simon D
4.1.3 - Heterologous Source Sensitized (SPT)2013ItalyIgE1888.88020131031, Bonura A
6.2 - General Population (Adults)2012SwedenIgE3715.93020120528, Patelis A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE23310.80020120726, Flores E
1.4 - Respiratory Symptoms, Diagnosed2012FranceIgE12923.30020121204, Caimmi D
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9943.43020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9626.04020120528, Patelis A
5.2.5 - Source Exposed, Children (Symptoms, IgE)2012Czech RepublicIgE8259.80020120424, Sekerkova A
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5446.30020120310, Twaroch TE
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012Czech RepublicIgE4879.10020120424, Sekerkova A
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2646.20020120310, Twaroch TE
1.4 - Respiratory Symptoms, Diagnosed2011SpainIgE6845.60020110509, Rodriguez D
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE4369.80020110713, Cabrera-Freitag P
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640821.98020100301, Scala E
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8610.46020101214, Gadisseur R
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3737.83020090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009AustriaIgE3219.00020090211, Constantin C
10.1 - Normal Control2009BelgiumIgE263.85020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009AustriaIgE2241.00020090211, Constantin C
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2222.73020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2080.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2040.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009AustriaIgE1788.00020090211, Constantin C
1.4 - Respiratory Symptoms, Diagnosed2008SpainIgE78628.75020081010, Barber D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaIgE8273.10020080314, Westritschnig K
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaSPT8271.95020080314, Westritschnig K
3.2.1 - Source Sensitized (IgE)2005FinlandIgE5760.00020041224, Moverare R
3.2.1 - Source Sensitized (IgE)2005FinlandIgE120.00020041224, Moverare R
3.1.1 - Source Sensitized (SPT)2003ItalyIgE74950.3002003, Mari A
3.2.1 - Source Sensitized (IgE)2003AustriaIgE25100.0002003a, Westritschnig K
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE2527.0002003a, Westritschnig K
3.1.1 - Source Sensitized (SPT)2001ItalyIgE36756.4002001a, Rossi RE
3.1.4 - Source Sensitized (SPT, IgE)2001ItalyIgE7772.7002001a, Rossi RE
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000ItalyIgE27659.4002000, Rossi RE
3.2.1 - Source Sensitized (IgE)1998NetherlandsIgE15455.2001998, van Ree R
5.2.1 - Source Exposed (Symptoms, SPT)1996FranceIgE3868.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996SwedenIgE3563.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996AustriaIgE2993.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996DenmarkIgE2692.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996JapanIgE2045.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996SwitzerlandIgE2060.0001996, Laffer S
5.2.1 - Source Exposed (Symptoms, SPT)1996CanadaIgE1567.0001996, Laffer S
5.3.1 - Source Exposed (Symptoms, IgE)1994AustriaIgE3070.0001994, Laffer S
Developed by
Panservice